BackZealand Pharma A/S. Overview

Zealand Pharma A/S. Receivables

Track Zealand Pharma A/S.'s receivables ($93M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$92.58M

Peer average

Loading

Zealand Pharma A/S. Receivables History

Loading

Zealand Pharma A/S. vs. peers: Receivables Comparison

Loading

Zealand Pharma A/S. Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Zealand Pharma A/S. (ZEAL) FAQ

Zealand Pharma A/S. (ZEAL) currently reports a receivables of $93M as of March 2022. Use the charts on this page to explore Zealand Pharma A/S.'s receivables history and peer comparisons.

Zealand Pharma A/S. reported $93M in receivables as of March 2022. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $93M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Zealand Pharma A/S., and consider following ZEAL for alerts when major investors trade the stock.

Zealand Pharma A/S. is classified in the Healthcare sector. On receivables, it currently shows $93M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ZEAL with unrelated industries.